Please Wait
Applying Filters...
menu
    • menu
    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-08-11

    Virtual Booth

    An Enquiry

    Menu

    Teduglutide Recombinant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,732,537Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OPKO, Entera Bio’s Oral GLP-2 Picked for 2025 ESPEN Congress
    OPKO, Entera Bio’s Oral GLP-2 Picked for 2025 ESPEN Congress

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3111697/0/en/OPKO-Health-and-Entera-Bio-Announce-Abstract-on-PK-PD-of-Oral-GLP-2-Tablet-for-the-Treatment-of-Short-Bowel-Syndrome-Selected-for-2025-ESPEN-Congress.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share
    Combo drugs: latest trend in local pharmaceuticals
    Combo drugs: latest trend in local pharmaceuticals

    19 Aug 2019

    // Lee Hye-seon KOREAMED

    http://www.koreabiomed.com/news/articleView.html?idxno=6300

    Lee Hye-seon KOREAMED
    19 Aug 2019
    Share Share
    U.S. FDA Approves GATTEX® for Children 1Y Age&Older With Short Bowel Syndrome
    U.S. FDA Approves GATTEX® for Children 1Y Age&Older With Short Bowel Syndrome

    17 May 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/us-fda-approves-gattex-teduglutide-for-children-1-year-of-age-and-older-with-short-bowel-syndrome-sbs-300852294.html

    PR NEWSWIRE
    17 May 2019
    Share Share
    Shire Moves to Protect Gattex From Par Generic Challenge
    Shire Moves to Protect Gattex From Par Generic Challenge

    31 Jul 2018

    // BLOOMBERG

    https://news.bloomberglaw.com/pharma-and-life-sciences/shire-moves-to-protect-gattex-from-par-generic-challenge?context=landing-heroes

    BLOOMBERG
    31 Jul 2018
    Share Share
    Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.
    Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.

    30 Jul 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/gattex-teduglutide-amlodipine-and-valsartan-tabs-shire-nps-pharm-v-par-pharma-et-al-1533038693.pdf

    PATENT LITIGATION
    30 Jul 2018
    Share Share
    SMC endorses five new therapies for NHS Scotland
    SMC endorses five new therapies for NHS Scotland

    10 Apr 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/smc_endorses_five_new_therapies_for_nhs_scotland_1231056

    Selina McKee PHARMA TIMES
    10 Apr 2018
    Share Share